Top

Substance Abuse Treatment, Prevention, and Policy

Published in:

01-12-2020 | Addiction | Research

A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use

Authors: David Wiercigroch, Hasan Sheikh, Jennifer Hulme

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2020

Abstract

Background

Substance use is prevalent in Canada, yet treatment is inaccessible. The Rapid Access to Addiction Medicine (RAAM) clinic opened at the University Health Network (UHN) in January 2018 as part of a larger network of addictions clinics in Toronto, Ontario, to enable timely, low barrier access to medical treatment for substance use disorder (SUD). Patients attend on a walk-in basis without requiring an appointment or referral. We describe the RAAM clinic model, including referral patterns, patient demographics and substance use patterns. Secondary outcomes include retention in treatment and changes in both self-reported and objective substance use.

Methods

The Electronic Medical Record at the clinic was reviewed for the first 26 weeks of the clinic’s operation. We identified SUD diagnoses, referral source, medications prescribed, retention in care and self-reported substance use.

Results

The clinic saw 64 unique patients: 66% had alcohol use disorder (AUD), 39% had opiate use disorder (OUD) and 20% had stimulant use disorder. Fifty-five percent of patients were referred from primary care providers, 30% from the emergency department and 11% from withdrawal management services. Forty-two percent remained on-going patients, 23% were discharged to other care and 34% were lost to follow-up. Gabapentin (39%), naltrexone (39%), and acamprosate (15%) were most frequently prescribed for AUD. Patients with AUD reported a significant decrease in alcohol consumption at their most recent visit. Most patients (65%) with OUD were prescribed buprenorphine, and most patients with OUD (65%) had a negative urine screen at their most recent visit.

Conclusion

The RAAM model provides low-barrier, accessible outpatient care for patients with substance use disorder and facilitates the prescription of evidence-based pharmacotherapy for AUD and OUD. Patients referred by their primary care physician and the emergency department demonstrated a reduction in median alcohol consumption and high rates of opioid abstinence.

Pearson C, Janz T, Ali J. Mental and substance use disorders in Canada [Internet]. Ottawa; 2015. Available from: https://www150.statcan.gc.ca/n1/pub/82-624-x/2013001/article/11855-eng.htm

Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: Recommendations and rationale. Am J Psychiatry. 2013;170:834–51.CrossRef

Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–66 Available from: https://www.ncbi.nlm.nih.gov/pubmed/28483845.CrossRef

Special Advisory Committee on the Epidemic of Opioid Overdoses. National report: Apparent opioid-related deaths in Canada (January 2016 to September 2018) [Internet]. Public Health Agency of Canada. 2018 [cited 2018 Sep 19]. Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/national-report-apparent-opioid-related-deaths-released-june-2018.html#a1

Canadian Institute for Health Information, Canadian Centre on Substance Abuse. Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada [Internet]. Ottawa; 2016. Available from: https://secure.cihi.ca/free_products/Opioid%20Poisoning%20Report%20%20EN.pdf

Gerstein DR, Lewin LS. Treating drug problems. N Engl J Med. 1990;323(12):844–8 Available from: https://www.ncbi.nlm.nih.gov/pubmed/2392142.CrossRef

McCollister KE, French MT. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings. Addiction. 2003;98(12):1647–59 [cited 2018 Sep 19] Available from: http://www.ncbi.nlm.nih.gov/pubmed/14651494.CrossRef

Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Heal Organ. 2004;82(11):858–66 2004/12/14 Available from: https://www.ncbi.nlm.nih.gov/pubmed/15640922.

Vipler S, Hayashi K, Milloy M-J, Wood E, Nosova E, Kerr T, et al. Use of withdrawal management services among people who use illicit drugs in Vancouver, Canada. Subst Abuse Treat Prev Pol. 2018;13(1):27 [cited 2018 Sep 19] Available from: http://www.ncbi.nlm.nih.gov/pubmed/29976225.CrossRef

10.

Keen J, Oliver P, Rowse G, Mathers N. Residential rehabilitation for drug users: a review of 13 months’ intake to a therapeutic community. Fam Pr. 2001;18(5):545–8 Available from: https://www.ncbi.nlm.nih.gov/pubmed/11604381.CrossRef

11.

Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23(2):63–75 Available from: https://www.ncbi.nlm.nih.gov/pubmed/25747920.CrossRef

12.

Festinger DS, Lamb RJ, Kountz MR, Kirby KC, Marlowe D. Pretreatment dropout as a function of treatment delay and client variables. Addict Behav. 1995;20(1):111–5 [cited 2018 Sep 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7785476.CrossRef

13.

Ross LE, Vigod S, Wishart J, Waese M, Spence JD, Oliver J, et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam Pract. 2015;16(1):135 [cited 2018 Sep 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26463083.CrossRef

14.

Levinson Miller C, Druss BG, Dombrowski EA, Rosenheck RA. Barriers to Primary Medical Care Among Patients at a Community Mental Health Center. Psychiatr Serv. 2003;54(8):1158–60 [cited 2018 Sep 19] Available from: http://www.ncbi.nlm.nih.gov/pubmed/12883146.CrossRef

15.

Mandelberg JH, Kuhn RE, Kohn MA. Epidemiologic analysis of an urban, public emergency department’s frequent users. Acad Emerg Med. 2000;7(6):637–46 [cited 2018 Sep 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10905642.CrossRef

16.

McLellan AT, Starrels JL, Tai B, Gordon AJ, Brown R, Ghitza U, et al. Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group. Public Health Rev. 2014;35(2) [cited 2019 Mar 14] Available from: https://publichealthreviews.biomedcentral.com/track/pdf/10.1007/BF03391707.

17.

Gee PM, Greenwood DA, Paterniti DA, Ward D, LMS M. The eHealth enhanced chronic care model: A theory derivation approach. J Med Internet Res. 2015;17:e86.CrossRef

18.

Netherland J, Botsko M, Egan JE, Fiellin DA, Saxon AJ, Cunningham CO, et al. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2008;36(3):244–51 [cited 2019 mar 14]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18715741.CrossRef

19.

META:PHI. Mentoring, Education, and Clinical Tools for Addiction: Primary Care-Hospital Integration. A provincial initiative to support health care providers in treating people struggling with substance use disorders [Internet]. Women’s College Hospital. 2018. Available from: http://www.metaphi.ca/

20.

Longabaugh R, Minugh PA, Nirenberg TD, Clifford PR, Becker B, Woolard R. Injury as a motivator to reduce drinking. Acad Emerg Med. 1995;2(9):817–25 [cited 2018 Sep 19] Available from: http://www.ncbi.nlm.nih.gov/pubmed/7584769.CrossRef

21.

Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, et al. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5 [cited 2018 Sep 19] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0740547217301174.CrossRef

22.

Moallem NR, Courtney KE, Bacio GA, Ray LA. Modeling alcohol use disorder severity: An integrative structural equation modeling approach. Front Psychiatry. 2013;4(JUL):75.PubMedPubMedCentral

23.

Butt P, Beriness D, Gliksman L, Paradis C, Stockwell T. Alcohol and health in Canada: A summary of evidence and guidelines for low risk drinking [Internet]. Ottawa; 2011 [cited 2018 Sep 19]. Available from: http://www.ccsa.ca/Eng/topics/alcohol/

24.

Family Health Teams [Internet]. Ontario Ministry of Health and Long-Term Care. 2016. Available from: http://www.health.gov.on.ca/en/pro/programs/fht/

25.

Friedmann PD, Lemon SC, Stein MD, D’Aunno TA. Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations. Heal Serv Res. 2003;38(3):887–903 Available from: https://www.ncbi.nlm.nih.gov/pubmed/12822917.CrossRef

26.

Kaplan EH, Johri M. Treatment on demand: an operational model. Heal Care Manag Sci. 2000;3(3):171–83 Available from: https://www.ncbi.nlm.nih.gov/pubmed/10907320.CrossRef

27.

R Core Team. R. A language and environment for statistical computing [Internet]. Vienna, Austria: R foundation for Statistical Computing; 2017. Available from: https://www.r-project.org/

28.

Miller JM. GraphPad PRISM. Vol. 52, Analysis. San Diego, California: GraphPad Software; 2003. p. 2–3.

29.

Fischer B, Argento E. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician. 2012;15(3 Suppl):ES191–203 Available from: https://www.ncbi.nlm.nih.gov/pubmed/22786457.PubMed

30.

Spithoff S, Turner S, Gomes T, Martins D, Singh S. First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario. Can Fam Physician. 2017;63(5):e277–83 [cited 2018 Sep 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28500210.PubMedPubMedCentral

31.

Bruneau J, Ahamad K, Goyer M, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247–57 Available from: https://www.ncbi.nlm.nih.gov/pubmed/29507156.CrossRef

32.

Socías ME, Ahamad K. An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders. CMAJ. 2016;188(17–18):1208–9 [cited 2018 Sep 19] Available from: http://www.cmaj.ca/lookup/doi/10.1503/cmaj.160554.CrossRef

33.

Blow FC, Walton MA, Barry KL, Murray RL, Cunningham RM, Massey LS, et al. Alcohol and drug use among patients presenting to an inner-city emergency department: A latent class analysis. Addict Behav. 2011;36(8):793–800 [cited 2019 Jun 4] Available from: https://www.sciencedirect.com/science/article/abs/pii/S0306460310003783.CrossRef

34.

Trinks A, Festin K, Bendtsen P, Cherpitel CJ, Nilsen P. Acute alcohol consumption and motivation to reduce drinking among injured patients in a Swedish emergency department. J Addict Nurs. 2012;23(3):152–8 [cited 2018 Sep 19] Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00060867-201210000-00002.CrossRef

35.

Hu T, Snider-Adler M, Nijmeh L, Pyle A. Buprenorphine/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers. CJEM. 2019:1–7 [cited 2019 Jun 4] Available from: https://www.cambridge.org/core/product/identifier/S1481803519000241/type/journal_article.

36.

Wiclkzer T, Maynard C, Atherly A, Frederick MPHM, Koepsell T, Knrpsk A, et al. Completion Rates of Clients Discharged from Drug and Alcohol Treatment Programs in Washington State. Am J Public Health. 1994;84(2):215–21 [cited 2019 Apr 1] Available from: https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.84.2.215.CrossRef

37.

Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369–76 [cited 2018 Sep 19] Available from: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2014.2556.CrossRef

38.

Bell J, Trinh L, Butler B, Randall D, Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104(7):1193–200 Available from: https://www.ncbi.nlm.nih.gov/pubmed/19563562.CrossRef

39.

Tuithof M, ten Have M, van den Brink W, Vollebergh W, de Graaf R. Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder. Drug Alcohol Depend. 2014;140:85–91 [cited 2018 Sep 20] Available from: http://linkinghub.elsevier.com/retrieve/pii/S0376871614008278.CrossRef

40.

Miller MM. Evaluating Addiction Treatment Outcomes. Addict Disord Their Treat. 2007;6(3):101–6 [cited 2019 Nov 10] Available from: https://insights.ovid.com/crossref?an=00132576-200709000-00002.CrossRef

41.

Mccaul ME, Svikis DS, Moore RD. Predictors of outpatient treatment retention: patient versus substance use characteristics [Internet]. Vol. 62. Drug Alcohol Dependence. 2001; [cited 2019 Nov 10]. Available from: www.elsevier.com/locate/drugalcdep.

Title: A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
Authors: David Wiercigroch
Hasan Sheikh
Jennifer Hulme
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Addiction
Buprenorphine
Opioids
Opioids
Care
Addiction
Published in: Substance Abuse Treatment, Prevention, and Policy / Issue 1/2020
Electronic ISSN: 1747-597X
DOI: https://doi.org/10.1186/s13011-019-0250-1

At a glance: The STEP trials

Springer Medicine

A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2020

Factors predicting satisfaction in outpatient substance abuse treatment: a prospective follow-up study

Socioeconomic resources and quality of life in alcohol use disorder patients: the mediating effects of social support and depression

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway

PTSD and opioid use: implications for intervention and policy

The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms

A review of the public sector substance use disorder treatment and prevention systems in Kenya